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Introduction 
7α-hydroxy-4-cholesten-3-one (7HCO) is a reliable method to diagnose bile acid 
malabsorption (BAM). Since 7HCO is an intermediate metabolite in the bile acid 
synthesis, increased levels reflect bile acid production, which is the case in BAM.  
Aims & Methods 
We evaluate retrospectively, prospectively collected clinical data during the first year 
after implementation of a new test using ultra-high performance liquid 
chromatography coupled to mass spectrometry to measure 7HCO. In adult patients 
with clinical suspicion of BAM, unexplained diarrhea and a subgroup with obesity 
7HCO was measured. Levels < 30 ng/ml are considered as normal values. The 
decision to treat with cholestyramine was at the discretion of the treating physicians.  
Results 
We performed 126 7HCO analysis in 112 patients (62% female, mean age 5116 
years) with a mean level of 8491ng/ml. Cholestyramin treatment was more likely 
initiated in patients with Crohn’s disease (RR 1.8; 95%CI 0.9-3.7) or after ileocecal 
resection (RR 3.1; 95%CI 1.7-5.7). Diarrhea improved in 60% of patients with a 
7HCO level above 40 ng/ml. Thresholds of 60 or 100 ng/ml do not improve 
prediction of response to cholestyramin treatment  
 
Table: 7HCO measurement in subgroups 
Subgroups Number Mean [ng/ml] SD Range# 
Diarrhea  79 94* 96 <5 - >300 
No diarrhea 33 59* 71 <5 - >300 
Cholestyramin treated 27 167§ 105 11 - >300 
Cholestyramin untreated 85 57§ 67 <5 - >300 
Crohn’s disease (CD) 18 182 105 13 - >300 
Ileocecal resection (IR) 26 197 105 28 - >300 
CD + IR 13 214 95 41 - >300 
Obese (BMI 39.1kg/m2) 21 62 49 6 - 244 
*p<0.05; §p<0.001; #Validation Range 5 – 300 ng/mL 
 
Conclusion 
A 7HCO measurement above 40 ng/ml seems to be associated with a good 
response to cholestyramine treatment, which suggests clinical bile acid 
malabsorption. However, most patients have higher levels, particularly in Crohn’s 
disease after ileocecal resection. These preliminary results warranted confirmation 
on a larger scale. s
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